ScaleiQ Research

---

We are advancing hybrid quantum machine learning to unlock patterns in complex clinical data beyond the reach of classical AI. Combined with continuous, longitudinal measurement, this approach enables a dynamic view of patient health driving earlier insights, more precise monitoring, and a deeper understanding of disease over time.

At ScaleiQ, we are advancing a new frontier in clinical research through hybrid quantum machine learning. By combining quantum and classical computing, we aim to uncover patterns in complex clinical and biological data that remain beyond the reach of traditional approaches.

Our research focuses on enhancing biomarker discovery, disease modeling, and treatment response by exploring high-dimensional data across imaging, clinical, and real-world evidence. As these technologies evolve, they offer the potential to accelerate insight and enable more precise, data-driven decision-making.

Central to this vision is longitudinal measurement. We are building systems that continuously integrate data over time, creating a dynamic, evolving view of patient health—shifting clinical research from static analysis to continuous, predictive insight.